These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31744780)

  • 1. Discovery of novel nonpeptide small-molecule NRP1 antagonists: Virtual screening, molecular simulation and structural modification.
    Peng K; Li Y; Bai Y; Jiang T; Sun H; Zhu Q; Xu Y
    Bioorg Med Chem; 2020 Jan; 28(1):115183. PubMed ID: 31744780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Architecture and hydration of the arginine-binding site of neuropilin-1.
    Mota F; Fotinou C; Rana RR; Chan AWE; Yelland T; Arooz MT; O'Leary AP; Hutton J; Frankel P; Zachary I; Selwood D; Djordjevic S
    FEBS J; 2018 Apr; 285(7):1290-1304. PubMed ID: 29430837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of natural 15-LOX small molecule inhibitors from Chinese herbal medicine using virtual Screening, biological evaluation and molecular dynamics studies.
    Li Y; Zhang Y; Wu X; Gao Y; Guo J; Tian Y; Lin Z; Wang X
    Bioorg Chem; 2021 Oct; 115():105197. PubMed ID: 34426159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel inhibitors of vascular endothelial growth factor-A-Neuropilin-1 interaction by structure-based virtual screening.
    Starzec A; Miteva MA; Ladam P; Villoutreix BO; Perret GY
    Bioorg Med Chem; 2014 Aug; 22(15):4042-8. PubMed ID: 24961874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential inhibitors interacting in Neuropilin-1 to develop an adjuvant drug against COVID-19, by molecular docking.
    Vique-Sánchez JL
    Bioorg Med Chem; 2021 Mar; 33():116040. PubMed ID: 33515918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-Cells.
    Powell J; Mota F; Steadman D; Soudy C; Miyauchi JT; Crosby S; Jarvis A; Reisinger T; Winfield N; Evans G; Finniear A; Yelland T; Chou YT; Chan AWE; O'Leary A; Cheng L; Liu D; Fotinou C; Milagre C; Martin JF; Jia H; Frankel P; Djordjevic S; Tsirka SE; Zachary IC; Selwood DL
    J Med Chem; 2018 May; 61(9):4135-4154. PubMed ID: 29648813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction.
    Jarvis A; Allerston CK; Jia H; Herzog B; Garza-Garcia A; Winfield N; Ellard K; Aqil R; Lynch R; Chapman C; Hartzoulakis B; Nally J; Stewart M; Cheng L; Menon M; Tickner M; Djordjevic S; Driscoll PC; Zachary I; Selwood DL
    J Med Chem; 2010 Mar; 53(5):2215-26. PubMed ID: 20151671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating pharmacophore mapping, virtual screening, density functional theory, molecular simulation towards the discovery of novel apolipoprotein (apoE ε4) inhibitors.
    Johari S; Sharma A; Sinha S; Das A
    Comput Biol Chem; 2019 Apr; 79():83-90. PubMed ID: 30743160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal modification of VEGF-A C terminus-derived peptides delineates structural features involved in neuropilin-1 binding and functional activity.
    Jia H; Aqil R; Cheng L; Chapman C; Shaikh S; Jarvis A; Chan AW; Hartzoulakis B; Evans IM; Frolov A; Martin J; Frankel P; Djordevic S; Zachary IC; Selwood DL
    Chembiochem; 2014 May; 15(8):1161-70. PubMed ID: 24771685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting.
    Pan Q; Chathery Y; Wu Y; Rathore N; Tong RK; Peale F; Bagri A; Tessier-Lavigne M; Koch AW; Watts RJ
    J Biol Chem; 2007 Aug; 282(33):24049-56. PubMed ID: 17575273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.
    Zaka M; Abbasi BH; Durdagi S
    J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach.
    Aarthy M; Singh SK
    Curr Top Med Chem; 2018; 18(18):1585-1602. PubMed ID: 30360716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics to enhance structure-based virtual screening on cathepsin B.
    Ogrizek M; Turk S; Lešnik S; Sosič I; Hodošček M; Mirković B; Kos J; Janežič D; Gobec S; Konc J
    J Comput Aided Mol Des; 2015 Aug; 29(8):707-12. PubMed ID: 25947277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF (Vascular Endothelial Growth Factor) Induces NRP1 (Neuropilin-1) Cleavage via ADAMs (a Disintegrin and Metalloproteinase) 9 and 10 to Generate Novel Carboxy-Terminal NRP1 Fragments That Regulate Angiogenic Signaling.
    Mehta V; Fields L; Evans IM; Yamaji M; Pellet-Many C; Jones T; Mahmoud M; Zachary I
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1845-1858. PubMed ID: 29880492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of protein-protein binding disruptors using multi-component condensations small molecules.
    Bedjeguelal K; Bienaymé H; Dumoulin A; Poigny S; Schmitt P; Tam E
    Bioorg Med Chem Lett; 2006 Aug; 16(15):3998-4001. PubMed ID: 16765048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based discovery of novel small molecule inhibitors of platelet-derived growth factor-B.
    Zarei O; Sarri N; Dastmalchi S; Zokai F; Papadopoulos N; Lennartsson J; Heldin CH; Hamzeh-Mivehroud M
    Bioorg Chem; 2020 Jan; 94():103374. PubMed ID: 31699389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combinatorial approach of structure-based virtual screening and molecular dynamics simulation towards the discovery of a highly selective inhibitor for VP9 coat protein of Banna virus.
    Moitra P
    Bioorg Chem; 2019 May; 86():15-27. PubMed ID: 30684859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microplate-based screening for small molecule inhibitors of neuropilin-2/vascular endothelial growth factor-C interactions.
    Parker MW; Vander Kooi CW
    Anal Biochem; 2014 May; 453():4-6. PubMed ID: 24583243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin Fc-Fused Peptide without C-Terminal Arg or Lys Residue Augments Neuropilin-1-Dependent Tumor Vascular Permeability.
    Baek DS; Kim JH; Kim YJ; Kim YS
    Mol Pharm; 2018 Feb; 15(2):394-402. PubMed ID: 29232521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.